甲状腺微小乳头状癌右侧喉返神经后方淋巴结转移相关危险因素Meta分析

王慧芳, 于博, 赵文君, 等. 甲状腺微小乳头状癌右侧喉返神经后方淋巴结转移相关危险因素Meta分析[J]. 临床耳鼻咽喉头颈外科杂志, 2021, 35(3): 245-251. doi: 10.13201/j.issn.2096-7993.2021.03.012
引用本文: 王慧芳, 于博, 赵文君, 等. 甲状腺微小乳头状癌右侧喉返神经后方淋巴结转移相关危险因素Meta分析[J]. 临床耳鼻咽喉头颈外科杂志, 2021, 35(3): 245-251. doi: 10.13201/j.issn.2096-7993.2021.03.012
WANG Huifang, YU Bo, ZHAO Wenjun, et al. A Meta-analysis of risk factors related to the lymph nodes posterior to the right recurrent laryngeal nerve in thyroid micropapillary carcinoma[J]. J Clin Otorhinolaryngol Head Neck Surg, 2021, 35(3): 245-251. doi: 10.13201/j.issn.2096-7993.2021.03.012
Citation: WANG Huifang, YU Bo, ZHAO Wenjun, et al. A Meta-analysis of risk factors related to the lymph nodes posterior to the right recurrent laryngeal nerve in thyroid micropapillary carcinoma[J]. J Clin Otorhinolaryngol Head Neck Surg, 2021, 35(3): 245-251. doi: 10.13201/j.issn.2096-7993.2021.03.012

甲状腺微小乳头状癌右侧喉返神经后方淋巴结转移相关危险因素Meta分析

  • 基金项目:
    山西省重点研发计划项目(No:201903D321147)
详细信息

A Meta-analysis of risk factors related to the lymph nodes posterior to the right recurrent laryngeal nerve in thyroid micropapillary carcinoma

More Information
  • 目的 通过Meta分析探讨甲状腺微小乳头状癌(PTMC)右侧喉返神经后方(Ⅵb区)淋巴结转移的危险因素。方法 检索国内外文献数据库中PTMC喉返神经后方淋巴结转移相关的文献, 检索截止时间是2020年6月, 由两名研究者筛选文献、提取数据后, 采用Revman5.3软件进行Meta分析。结果 共纳入5篇文章, 共计1884例研究对象, 研究结果显示: PTMC Ⅵb区淋巴结转移率为10.8%(203/1884), 转移危险因素包括患者年龄 < 45岁, 男性, 右叶肿瘤直径≥0.5 cm, 侵出包膜, Ⅵa淋巴结转移。结论 对PTMC有Ⅵb区淋巴结转移高危因素的患者应该行包含Ⅵb区淋巴结在内彻底的淋巴结清扫。
  • 加载中
  • 图 1  文献筛选流程图

    图 2  PTMC患者性别与Ⅵb区淋巴结转移相关性Meta分析森林图

    图 3  PTMC患者年龄与Ⅵb区淋巴结转移相关性Meta分析森林图

    图 4  PTMC患者右侧肿瘤直径与Ⅵb区淋巴结转移相关性Meta分析森林图

    图 5  PTMC患者肿瘤位置与Ⅵb区淋巴结转移相关性Meta分析森林图

    图 6  PTMC患者肿瘤侵出包膜与Ⅵb区淋巴结转移相关性Meta分析森林图

    图 7  PTMC患者肿瘤腺外侵犯与Ⅵb区淋巴结转移相关性Meta分析森林图

    图 8  PTMC患者多灶性与Ⅵb区淋巴结转移相关性Meta分析森林图

    图 9  PTMC合并桥本甲状腺炎与Ⅵb区淋巴结转移相关性Meta分析森林图

    图 10  PTMC Ⅵa区淋巴结转移与Ⅵb区淋巴结转移相关性Meta分析森林图

    表 1  纳入文献的基本特征

    作者 发表年份 时间跨度/年 例数 Ⅵb区淋巴结转移/例(%) 中央区淋巴结清扫适应证 NOS评分
    刘文等[11] 2017 2013-2016 772 55(7.1) 预防/治疗性清扫 7
    万福强等[12] 2017 2010-2015 305 34(11.1) 预防性清扫 6
    孙振华等[13] 2020 2016-2019 175 61(37.1) 预防/治疗性清扫 6
    彭冬梅等[14] 2016 2012-2015 294 25(8.5) 预防性清扫 6
    Li等[15] 2019 2015-2017 338 28(8.3) 预防性清扫 7
    下载: 导出CSV

    表 2  Ⅵb区淋巴结转移危险因素

    危险因素 OR 95%CI P
    年龄(< 45岁) 1.72 1.29~2.28 0.01
    男性 2.15 1.55~2.98 < 0.01
    右叶肿瘤直径(≥ 0.5 cm) 2.82 1.82~4.36 < 0.01
    肿瘤位置(右叶上级) 1.12 0.59~2.12 0.73
    侵出包膜 3.78 2.35~6.08 < 0.01
    腺外侵犯 1.84 0.74~4.58 0.19
    多灶性 2.16 0.89~5.21 0.09
    桥本甲状腺炎 0.99 0.65~1.53 0.98
    Ⅵa区淋巴结转移 7.40 4.88~11.21 <0.01
    下载: 导出CSV
  • [1]

    Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020[J]. CA Cancer J Clin, 2020, 70(1): 7-30. doi: 10.3322/caac.21590

    [2]

    Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018[J]. CA Cancer J Clin, 2018, 68(1): 7-30. doi: 10.3322/caac.21442

    [3]

    伍波, 樊友本. 我国甲状腺癌治疗现状: 不足、不规范和过度并存[J]. 浙江医学, 2017, 39(11): 857-859, 870. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJYE201711001.htm

    [4]

    王龙龙, 李红强, 苌群刚, 等. 甲状腺癌21 980例患者临床病理特征与发病趋势分析[J]. 中华医学杂志, 2020, 100(14): 1072-1076. doi: 10.3760/cma.j.cn112137-20190905-01972

    [5]

    Zhang Q, Wang Z, Meng X, et al. Predictors for central lymph node Metastases in CN0 papillary thyroid microcarcinoma(mPTC): A retrospective analysis of 1304 cases[J]. Asian J Surg, 2019, 42(4): 571-576. doi: 10.1016/j.asjsur.2018.08.013

    [6]

    Liu LS, Liang J, Li JH, et al. The incidence and risk factors for central lymph node Metastasis in cN0 papillary thyroid microcarcinoma: a Meta-analysis[J]. Eur Arch Otorhinolaryngol, 2017, 274(3): 1327-1338. doi: 10.1007/s00405-016-4302-0

    [7]

    中国抗癌协会甲状腺癌专业委员会(CATO). 甲状腺微小乳头状癌诊断与治疗中国专家共识(2016版)[J]. 中国肿瘤临床, 2016, 43(10): 405-411. doi: 10.3969/j.issn.1000-8179.2016.10.001

    [8]

    Pitoia F, Miyauchi A. 2015 American Thyroid Association Guidelines for Thyroid Nodules and Differentiated Thyroid Cancer and Their Implementation in Various Care Settings[J]. Thyroid, 2016, 26(2): 319-21. doi: 10.1089/thy.2015.0530

    [9]

    Abboud B, Smayra T, Jabbour H, et al. Correlations of neck ultrasound and pathology in cerⅥcal lymph node of papillary thyroid carcinoma[J]. Acta Chir Belg, 2020, 120(4): 238-244. doi: 10.1080/00015458.2019.1592988

    [10]

    王晓庆, 魏玮, 魏玺, 等. 甲状腺乳头状癌的超声表现及其与颈部中央区淋巴结转移的关系[J]. 中华肿瘤杂志, 2018, 40(3): 196-200. doi: 10.3760/cma.j.issn.0253-3766.2018.03.007

    [11]

    刘文, 程若川, 苏艳军, 等. 甲状腺微小乳头状癌rⅥb区转移预测因素及rⅥa区、rⅥb区转移相关性研究[J]. 中国实用外科杂志, 2017, 37(9): 1007-1012. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWK201709017.htm

    [12]

    万福强, 安玉胜, 任忠峰, 等. 右喉返神经后方淋巴结清扫在cN0期甲状腺乳头状微小癌手术中的探讨[J]. 中国综合临床, 2017, 33(11): 981-984. doi: 10.3760/cma.j.issn.1008-6315.2017.11.006

    [13]

    孙振华, 赵志泓, 蒋华平. 甲状腺微小乳头状癌rⅥb区淋巴结转移因素分析及术中纳米碳应用价值研究[J]. 临床耳鼻咽喉头颈外科杂志, 2020, 34(4): 355-359. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH202004017.htm

    [14]

    彭冬梅, 晏晨, 苏安平, 等. cN0甲状腺微小乳头状癌右侧喉返神经浅面及深面淋巴结转移危险因素分析[J]. 中国实用外科杂志, 2016, 36(5): 547-551. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGWK201605025.htm

    [15]

    Li F, Wu Y, Chen L, et al. Evaluation of clinical risk factors for predicting insidious right central and posterior right recurrent laryngeal nerve lymph node Metastasis in papillary thyroid microcarcinoma patients(cN0): experience of a single center[J]. Ann Transl Med, 2019, 7(1): 8-8. doi: 10.21037/atm.2018.12.43

    [16]

    Maksimovic S, Jakovljevic B, Gojkovic Z. Lymph Node Metastases Papillary Thyroid Carcinoma and their Importance in Recurrence of Disease[J]. Med Arch, 2018, 72(2): 108-111. doi: 10.5455/medarh.2018.72.108-111

    [17]

    胡照洋, 张自杰, 李长键, 等. 甲状腺再次手术治疗的临床分析[J]. 现代生物医学进展, 2017, 17(21): 4086-4088, 4127. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX201721022.htm

    [18]

    安祥, 余丹, 李兵. 预防性中央区淋巴结清扫对甲状腺微小乳头状癌患者预后影响的Meta分析[J]. 临床耳鼻咽喉头颈外科杂志, 2019, 33(2): 138-142. https://www.cnki.com.cn/Article/CJFDTOTAL-LCEH201902011.htm

    [19]

    Su H, Li Y. Prophylactic central neck dissection and local recurrence in papillary thyroid microcarcinoma: a Meta-analysis[J]. Braz J Otorhinolaryngol, 2019, 85(2): 237-243. doi: 10.1016/j.bjorl.2018.05.004

    [20]

    Wang TS, Evans DB, Fareau GG, et al. Effect of prophylactic central compartment neck dissection on serum thyroglobulin and recommendations for adjuvant radioactive iodine in patients with differentiated thyroid cancer[J]. Ann Surg Oncol, 2012, 19(13): 4217-4222. doi: 10.1245/s10434-012-2594-x

    [21]

    Lan X, Sun W, Zhang H, et al. A Meta-analysis of Central Lymph Node Metastasis for Predicting Lateral Involvement in Papillary Thyroid Carcinoma[J]. Otolaryngol Head Neck Surg, 2015, 153(5): 731-738. doi: 10.1177/0194599815601412

    [22]

    Randolph GW, Duh QY, Heller KS, et al. The prognostic significance of nodal Metastases from papillary thyroid carcinoma can be stratified based on the size and number of Metastatic lymph nodes, as well as the presence of extranodal extension[J]. Thyroid, 2012, 22(11): 1144-1152. doi: 10.1089/thy.2012.0043

    [23]

    Chen L, Wu YH, Lee CH, et al. Prophylactic Central Neck Dissection for Papillary Thyroid Carcinoma with Clinically Uninvolved Central Neck Lymph Nodes: A Systematic ReⅥew and Meta-analysis[J]. World J Surg, 2018, 42(9): 2846-2857. doi: 10.1007/s00268-018-4547-4

    [24]

    Shao L, Sun W, Zhang H, et al. Risk factors for right paraesophageal lymph node Metastasis in papillary thyroid carcinoma: A Meta-analysis[J]. Surg Oncol, 2020, 32: 90-98. doi: 10.1016/j.suronc.2019.11.007

    [25]

    Hwangbo Y, Kim JM, Park YJ, et al. Long-Term Recurrence of Small Papillary Thyroid Cancer and Its Risk Factors in a Korean Multicenter Study[J]. J Clin Endocrinol Metab, 2017, 102(2): 625-633.

    [26]

    Yuan J, Li J, Chen X, et al. Identification of risk factors of central lymph node Metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma[J]. Bull Cancer, 2017, 104(6): 516-523. doi: 10.1016/j.bulcan.2017.03.005

    [27]

    Li C, Xiang J, Wang Y. Risk Factors for Predicting Lymph Nodes Posterior to Right Recurrent Laryngeal Nerve(LN-prRLN)Metastasis in Thyroid Papillary Carcinoma: A Meta-Analysis[J]. Int J Endocrinol, 2019, 2019: 7064328.

    [28]

    邱贝, 赵波, 王涛, 等. 基于倾向评分匹配分析甲状腺乳头状癌多灶性对不良预后的影响[J]. 中华医学杂志, 2019, 99(30): 2332-2336. doi: 10.3760/cma.j.issn.0376-2491.2019.30.003

    [29]

    Zhu F, Shen YB, Li FQ, et al. The Effects of Hashimoto Thyroiditis on Lymph Node Metastases in Unifocal and Multifocal Papillary Thyroid Carcinoma: A Retrospective Chinese Cohort Study[J]. Medicine(Baltimore), 2016, 95(6): e2674.

    [30]

    Hussein O, Abdelwahab K, Hamdy O, et al. Thyroid cancer associated with Hashimoto thyroiditis: similarities and differences in an endemic area[J]. J Egypt Natl Canc Inst, 2020, 32(1): 7-7. doi: 10.1186/s43046-020-0017-9

    [31]

    Zhang L, Liu H, Xie Y, et al. Risk factors and indication for dissection of right paraesophageal lymph node Metastasis in papillary thyroid carcinoma[J]. Eur J Surg Oncol, 2016, 42(1): 81-86. doi: 10.1016/j.ejso.2015.10.011

    [32]

    Hou J, Shan H, Zhang Y, et al. Risk factors of Metastasis to the lymph nodes posterior to the right recurrent laryngeal nerve in papillary thyroid carcinoma[J]. Eur Arch Otorhinolaryngol, 2020, 277(3): 881-886. doi: 10.1007/s00405-019-05748-3

  • 加载中

(10)

(2)

计量
  • 文章访问数:  1626
  • PDF下载数:  399
  • 施引文献:  0
出版历程
收稿日期:  2020-06-14
刊出日期:  2021-03-05

目录